Interojo Inc. (KOSDAQ:119610)
South Korea · Delayed Price · Currency is KRW 15,020
-560 (-3.59%)
Jul 16, 2026, 3:30 PM KST
Interojo Market Cap
Interojo has a market cap or net worth of 171.03 billion as of July 17, 2026. Its market cap has decreased by -19.60% in one year.
Market Cap
171.03B
Enterprise Value
189.62B
Revenue
126.03B
Ranking
n/a
PE Ratio
11.36
Stock Price
15,020.00
ChartMarket Cap Chart
Since July 28, 2010, Interojo's market cap has increased from 44.29B to 171.03B, an increase of 286.17%. That is a compound annual growth rate of 8.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 171.03B | -6.41% |
| Dec 30, 2025 | 182.73B | -53.77% |
| Dec 28, 2023 | 395.31B | 11.81% |
| Dec 29, 2022 | 353.55B | -0.83% |
| Dec 30, 2021 | 356.49B | 45.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.62T |
| Celltrion | 40.32T |
| ALTEOGEN | 14.81T |
| Samsung Epis Holdings | 9.85T |
| JW Lifescience | 176.21B |
| HLB Therapeutics | 171.62B |
| Daewon Pharmaceutical | 170.61B |
| DIO Corporation | 166.24B |